Medidata and Pharm-Olam International have signed a new, five-year enterprise agreement to unify operational systems supporting study execution on Medidata Cloud.
Pharm-Olam previously used multiple systems and vendors, which led to duplicate data and silos requiring later integration. With Medidata, the global contract research organisation (CRO) will empower sponsors to accelerate drug therapy time to market by providing a single, unified view of clinical trials to all stakeholders.
Read more: http://www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852